Clinical Trials on Luteal Phase Progesterone Levels

Total 31 results

Hacettepe University
Anatolia IVF and Women's Health Center

Completed

The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates

Luteal Phase Progesterone Levels

Brazil, Denmark, Turkey
Universita di Verona

Completed

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support (PROPER-1)

In Vitro Fertilization | Progesterone | Luteal Phase Support

Italy
Sezcan Mumusoglu

Completed

The Effect of Progesterone Levels on Pregnancy

Relationship of Progesterone Levels and Pregnancy

Turkey
Cairo University

Completed

Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles

Frozen Embryo Transfer | Progesterone Supplementation | Serum Progesterone Levels | Clinical Pregnancy Rates | Ongoing Pregnancy Rates

Egypt
University of Athens
Iaso Maternity Hospital, Athens, Greece

Recruiting

Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles

Luteal Phase

Greece
Mansoura Integrated Fertility Center

Completed

Effect of Timing Progesterone Luteal Support on Embryo Transfer

Embryo Transfer | Progesterone Luteal Support in ICSI
Reproductive Medicine Associates of New Jersey

Completed

Effects of Varied Estrogen Doses on Endometrial Receptivity

Luteal Phase Defect

United States
Instituto Bernabeu

Completed

Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer. (CycloCT)

Luteal Phase Defect

Spain
Shaare Zedek Medical Center

Recruiting

Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates

Luteal Phase Support

Israel
IBSA Institut Biochimique SA

Withdrawn

Progesterone in Luteal Phase Deficiency

Luteal Phase Defect
University of Zagreb

Completed

Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

Luteal Phase Defect

Croatia
National University of Malaysia

Completed

Luteal Phase Support In IVF Women Using GnRH Agonist

Luteal Phase Defect | IVF

Malaysia
University of Alabama at Birmingham

Completed

Hormonal Effects on Pain Perception (HEPP)

Pregnancy | Progesterone Levels | Pregnancy Associated Analgesia

United States
Mỹ Đức Hospital

Completed

Early Luteal Hormones and IVF Outcomes After hCG Triggering

Luteal Phase | in Vitro Fertilisation

Vietnam
Regionshospitalet Viborg, Skive

Completed

The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

Infertility | Progesterone Levels

Denmark
Nordica Fertility Clinic
Merck Serono International SA

Unknown

A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

IVF - Luteal Phase Support After Embryo Transfer

Denmark, Sweden
Centrum Clinic IVF Center

Completed

Luteal Support in Frozen-Thawed Embryo Transfer Cycles

Luteal Phase Defect | Pregnancy Loss | Assisted Reproduction | Implantation; Placenta | Frozen Embryo | Luteal Support

Turkey
Fudan University

Recruiting

An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients (LPS-IHH)

Idiopathic Hypogonadotropic Hypogonadism | Luteal Phase Support | Luteal Phase Deficiency

China
Moustafa Mohammed Abouelea

Recruiting

Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles

Egypt
Penn State University
United States Department of Defense; National Institutes of Health (NIH); National...

Completed

Energy Restriction and Hormones in Premenopausal Women

Menstruation Disturbances | Luteal Phase Defect
Shaare Zedek Medical Center

Active, not recruiting

GnRH Agonist for Luteal Phase Support.

Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles

Israel
Penn State University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Bioenergetics of Exercise-Induced Menstrual Disturbances (BioE)

Menstruation Disturbances | Amenorrhea | Luteal Phase Defect | Oligomenorrhea
UMC Utrecht

Not yet recruiting

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment (LUMO)

Pregnancy Related | Fertility Issues | Luteal Phase Defect | Infertility Unexplained
Nordsjaellands Hospital
Yale University; Rigshospitalet, Denmark; BioIncept LLC

Completed

Early Pregnancy Cohort and Preimplantation Factor (PEP-cohort)

Pregnancy | Biomarkers | Abortion, Habitual | Abortion, Spontaneous | Luteal Phase
University Hospital, Ghent

Recruiting

Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone (PROTECTA)

Luteal Phase Defect | IVF | Embryo Loss

Belgium
Serum Institute of India Pvt. Ltd.
PPD

Completed

Safety Study of Dengushield in Healthy Adults

Dengue | Phase 1

Australia
Università degli Studi di Brescia
Ciro Costagliola; Francesco Semeraro; Roberto dell'Omo; Mario R Romano; Fabiana Aceto and other collaborators

Completed

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Myopic Choroidal Neovascularization | VEGF Aqueous Level | PEDF Aqueous Level

Italy
Novartis Pharmaceuticals

Terminated

Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations (MACS1148)

CML | Philadelphia Chromosome Positive (Ph+) | Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels

United States
National Cancer Institute (NCI)

Withdrawn

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions
Xencor, Inc.
ICON plc

Active, not recruiting

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (DUET-3)

Renal Cell Carcinoma | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Advanced Solid Tumors | Non-small Cell Lung Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Cervical Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma and other conditions

United States
National Cancer Institute (NCI)
Washington University Siteman Cancer Center

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Recurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Small Intestine Lymphoma | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Recurrent Endometrial Carcinoma | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Triple-negative... and other conditions

United States

Clinical Trials on Luteal Phase Progesterone Levels

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations